
Burning Rock Biotech Investor Relations Material
Latest events

Q1 2024
Burning Rock Biotech

Q1 2025
6 Jun, 2025

Q4 2024
25 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Burning Rock Biotech Limited
Access all reports
Burning Rock Biotech Limited focuses on developing and providing next-generation sequencing-based cancer therapy selection tests. The company offers comprehensive genomic profiling services and products for cancer patients to guide treatment decisions. Its key services include liquid biopsy, tissue biopsy, and companion diagnostic development, aimed at improving clinical outcomes for cancer patients. Burning Rock Biotech serves sectors such as oncology, biotechnology, and personalized medicine, collaborating with medical institutions, pharmaceutical companies, and research organizations. The company is headquartered in Guangzhou, China, and its shares are listed on the NASDAQ.
Key slides for Burning Rock Biotech Limited


Q4 2024
Burning Rock Biotech Limited


Q4 2024
Burning Rock Biotech Limited
Latest articles
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
Ticker symbol
BNR
Country
🇺🇸 United States